Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Phenobarbital 9 mg/mL Oral Suspension

FDA-approved generic
Dose form
Suspension
Active ingredients
Phenobarbital
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Phenobarbital
Suspension
66fd7b0bdc31c32733aec9f2
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded suspension containing phenobarbital, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved. Phenobarbital is a Schedule IV controlled substance.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing phenobarbital are listed in injection form, all for intravenous use. No finished phenobarbital product of any kind is listed in suspension form.

Storage category and dating

Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Phenobarbital is a Schedule IV barbiturate anticonvulsant and sedative that compounding pharmacies prepare by prescription in several dosage forms.

About this ingredient

Phenobarbital is a barbiturate that slows activity in the brain by acting on GABA-A receptors, keeping chloride channels open longer. Sezaby (phenobarbital sodium for injection) is FDA-approved for neonatal seizures in term and preterm infants and is not approved for adolescents or adults. MedlinePlus lists oral tablets and an elixir for seizures, anxiety and barbiturate withdrawal; DailyMed lists at least one current oral tablet label under the marketing category "unapproved drug other", and that label describes sedative and anticonvulsant use for generalized and partial seizures. A prescriber might order phenobarbital compounded for a strength, dosage form or vehicle that is not manufactured. Compounded preparations are not FDA-approved and require a prescription. Phenobarbital is a federally controlled Schedule IV substance.

Safety and interactions

Sezaby carries a boxed warning covering profound sedation, breathing problems, coma and death when used with opioids; dependence and withdrawal reactions after use longer than recommended; and abuse, misuse and addiction with unapproved use in adolescents and adults. Do not use phenobarbital with acute porphyria or a barbiturate allergy; the oral tablet label also lists marked liver impairment and respiratory disease with breathlessness or obstruction. Other warnings include serious skin reactions, DRESS, QT prolongation, sedation and suicidal thoughts. Do not stop it suddenly, because seizures can occur. MedlinePlus says it may make hormonal birth control less reliable, and it changes levels of many other drugs. Sezaby warns of fetal harm with use in adolescents and adults. LactMed advises watching breastfed infants for drowsiness, poor feeding and poor weight gain. Talk to your prescriber or pharmacist about side effects.

Phenobarbital is thought to potentiate GABA-A receptor-mediated synaptic inhibition (Sezaby label). StatPearls describes rapid, complete oral absorption with peak levels in 30 minutes to 1 hour, and 25 to 50% of the drug excreted unchanged in urine. The oral tablet label gives an adult plasma half-life of 53 to 118 hours (mean 79 hours) and describes phenobarbital as having the lowest plasma binding among barbiturates; Sezaby cites a neonatal half-life of about one week, reflecting negligible CYP2C9 at birth. It is metabolized mainly by CYP2C9, with CYP2C19, CYP2E1 and UGTs contributing. Per Sezaby, inhibitors of these pathways may require dose reduction, doses of CYP3A4, CYP2B6, CYP2C and UGT substrates may need adjustment, and drugs that prolong the QT interval should be avoided. Labeled indication: Sezaby for neonatal seizures in term and preterm infants. StatPearls describes use for status epilepticus and for benzodiazepine and alcohol withdrawal; these are not FDA-approved indications. Dosing is per prescriber. Monitor sedation, respiration, serum concentrations and signs of dependence. Phenobarbital is Schedule IV. Electronic prescribing of controlled substances is voluntary under federal DEA rules, CMS applies a prescriber-level threshold for Part D, and a number of states mandate it.

Sources

Using and storing

How it is used

Shake the bottle well before every dose so the medication is evenly mixed. Measure with the oral syringe or dosing cup provided, using the milliliter markings, and never a kitchen spoon. Take it by mouth as your label directs. Rinse the syringe after use and recap the bottle.

Storing it

Water-based suspensions are aqueous preparations. Under USP <795>, a preserved suspension usually carries a beyond-use date of up to 35 days at room temperature or refrigerated; an unpreserved one is refrigerated for up to 14 days. Oil-based suspensions are nonaqueous and may carry up to 90 days. Your label states storage and the beyond-use date. Keep out of reach of children and discard after that date.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Phenobarbital 9 mg/mL Oral Suspension
Suspension
30 mL
controlled

Take orally

Twice daily